Navigation Links
Volcano Corporation Provides Additional Guidance For 2013
Date:2/21/2013

Volcano's business that are not historical facts may be considered "forward-looking statements," including statements regarding Volcano's growth and other strategies and ability to execute on those strategies, competitive positioning, target markets, development of its base business and pipeline, benefits from recent acquisitions, benefits from its products and technologies and financial guidance. Forward-looking statements are based on management's current expectations and are subject to risks and uncertainties that may cause Volcano's actual results to differ materially and adversely from statements contained herein. Some of the potential risks and uncertainties that could cause actual results to differ include the risk that Volcano's revenue, expense, earnings, earnings per share, margin or other  projections may turn out to be inaccurate or Volcano may encounter unanticipated difficultly in achieving those projections; global and regional macroeconomic conditions, generally, and in the medical device and telecom industries specifically; currency exchange rate fluctuations; the effect of competitive factors and the company's reaction to those factors; purchasing decisions with respect to the company's products; the pace and extent of market adoption of the company's products and technologies; uncertainty in the process of obtaining regulatory approval or clearance for Volcano's products or devices; the success of Volcano's growth and other strategies including integration of recently-acquired businesses and our ability to integrate businesses from any future acquisitions; risks associated with Volcano's international operations; timing and achievement of product development milestones; outcome of ongoing or future litigation, investigations and claims; the impact and benefits of market development and the related size of Volcano's addressable markets; our ability to protect our intellectual property; dependence upon third parties; unexpected new data, safety
'/>"/>
SOURCE Volcano Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Volcano Announces Record Fourth Quarter Revenues
2. Volcano Corporation Schedules Fourth Quarter Conference Call, Webcast
3. Volcano Corporation Prices Offering Of $400 Million 1.75% Convertible Senior Notes Due 2017
4. Volcano Corporation To Offer $350 Million Convertible Senior Notes Due 2017
5. Volcano Corporation Signs Agreement to Acquire Sync-Rx Ltd.
6. Volcano Corporation Presentation At Piper Jaffray Conference To Be Webcast
7. Fish & Richardson Prevails in Patent Infringement Trial for Volcano Corporation
8. Volcano Corporation Schedules Third Quarter Conference Call, Webcast
9. Volcano Announces Previous St. Jude Medical Products Infringe Volcano Patent and Jury Verdicts in Patent Trials with St. Jude Medical
10. Volcano Corporation Presentation At Stifel Nicolaus Conference To Be Webcast
11. FAME 2 Published in the New England Journal of Medicine, Volcano participates in the $84M NIH-Sponsored ISCHEMIA Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... FAIRFAX, Va. , Aug. 21, 2014 /PRNewswire/ ... real-time quality and Manufacturing Intelligence , today ... Intelligence Conference. The event will be held Oct. ... Mile, and is designed to showcase the necessity ... use of metrics and Manufacturing Intelligence to gain ...
(Date:8/21/2014)... Professional Compounding Centers of America (PCCA) ... the three best scientific presentations at the sixth ... The Formulating Better Medicines for Children  conference, ... Athens, Greece , includes dozens of poster-style ... which three winners will be selected by a ...
(Date:8/21/2014)... 2014 Asterias Biotherapeutics, Inc. (OTCBB: ASTY), a ... medicine, announced today the appointments of Andrew ("Andy") Arno ... Board of Directors. With these additions, the Asterias Board ... are independent. Andy Arno , 55, ... companies. He is currently Managing Director of Emerging Growth ...
Breaking Medicine Technology:InfinityQS to Host Manufacturing Intelligence Conference in Chicago 2Professional Compounding Centers of America will award top poster-session winners at European Paediatric Formulation Initiative in Athens 2Asterias Biotherapeutics Appoints Two Independent Directors and Announces Completion of Series A Common Stock Distribution 2Asterias Biotherapeutics Appoints Two Independent Directors and Announces Completion of Series A Common Stock Distribution 3Asterias Biotherapeutics Appoints Two Independent Directors and Announces Completion of Series A Common Stock Distribution 4
... I Results Offer Hope of First Highly Effective Drug in ... June 1 Roche announced today results from a Phase ... promising treatment for patients with advanced melanoma whose cancer harbours ... PLX4032 lived for a median of at least six months ...
... Eli Lilly and Company announced today that Phase ... (gemcitabine HCl for injection) to the current standard of ... at three years for women with locally advanced cervical ... commonly diagnosed women,s cancer, and the second most common ...
Cached Medicine Technology:Encouraging First Data on New Targeted Treatment for Patients With Melanoma - the Deadliest Form of Skin Cancer 2Encouraging First Data on New Targeted Treatment for Patients With Melanoma - the Deadliest Form of Skin Cancer 3Encouraging First Data on New Targeted Treatment for Patients With Melanoma - the Deadliest Form of Skin Cancer 4Encouraging First Data on New Targeted Treatment for Patients With Melanoma - the Deadliest Form of Skin Cancer 5Study Showed Lilly's GEMZAR(R) (gemcitabine HCl for injection) Improved Progression-Free Survival in Cervical Cancer Patients 2Study Showed Lilly's GEMZAR(R) (gemcitabine HCl for injection) Improved Progression-Free Survival in Cervical Cancer Patients 3Study Showed Lilly's GEMZAR(R) (gemcitabine HCl for injection) Improved Progression-Free Survival in Cervical Cancer Patients 4Study Showed Lilly's GEMZAR(R) (gemcitabine HCl for injection) Improved Progression-Free Survival in Cervical Cancer Patients 5Study Showed Lilly's GEMZAR(R) (gemcitabine HCl for injection) Improved Progression-Free Survival in Cervical Cancer Patients 6
(Date:8/21/2014)... NV (PRWEB) August 21, 2014 ... Association for Packaging and Processing Technologies. They deliver ... the view into a whole new world of ... engaged attendees, interactive education, and the latest technology ... solutions from exhibitors. This year at Pack Expo ...
(Date:8/21/2014)... 22, 2014 BambooIndustry.com is an internationally ... company has recently unveiled its new collection of elegant ... made for customers who are looking for high quality ... are offered with great savings (up to 29 percent ... access these cheap products. , The company’s bamboo ...
(Date:8/21/2014)... Sterling Heights, MI (PRWEB) August 21, 2014 ... regarding emails informing a taxpayer that their federal tax ... the email domain appears to come from the IRS, ... unsuspecting victims to provide personal and financial information. , ... few years now, an uptick in phishing activity is ...
(Date:8/21/2014)... in the coronary arteries of chronic kidney disease patients ... according to a new study in the Journal ... ). Researchers at the Johns Hopkins Bloomberg School of ... commonly used measures of subclinical atherosclerosis in predicting the ... , Approximately 50 percent of all patients with chronic ...
(Date:8/21/2014)... August 21, 2014 Pulmonary Hypertension ... an Education Forum for PH patients and families ... Pulmonary Hypertension Association – the country’s ... ways to prevent and cure pulmonary hypertension (PH) ... the functioning of the heart and can lead ...
Breaking Medicine News(10 mins):Health News:Absolute I&D Provides Discounted Labor for Pack Expo Chicago 2Health News:Buy Elegant Bamboo Floorings from Internationally Well-known Supplier BambooIndustry.com 2Health News:Beware Of Phony “Tax Payment Rejected” IRS Emails 2Health News:Measuring calcium buildup to predict heart disease in those with chronic kidney disease 2Health News:Pulmonary Hypertension Association Goes On the Road to Houston With an Education Forum for PH Patients and Families to Help Fight Rare Lung Disease 2Health News:Pulmonary Hypertension Association Goes On the Road to Houston With an Education Forum for PH Patients and Families to Help Fight Rare Lung Disease 3
... of acres of farmland affected by last October,s red mud ... threat to a bountiful harvest, not toxic metals. In a ... also describe an inexpensive decontamination strategy using the mineral gypsum, ... note that a dam burst at a factory processing aluminum ...
... espionage agents probing an enemy,s fortifications, scientists are snooping ... that plants use to protect themselves from diseases. The ... natural defenses and enhance the safety and security of ... an article in the current edition of Chemical & ...
... Teenage girls and young women infected with HIV get pregnant ... HIV-negative peers, according to new research led by Johns Hopkins ... on an analysis of records from 181 patients with HIV, ... years, will be published in the Feb. 2 issue of ...
... keep hospital patients safe and continually improve the overall ... figure out a way to get physicians more involved ... patient care make their contributions to improvement efforts essential," ... patient safety expert and co-author of a commentary published ...
... Figures from a recently compiled report for 2009-2010 show ... students made a $6.8 million economic impact in the ... Education Centers. Specifically, AHEC faculty from UofL provided ... a total of $124,363 in living and travel expenses ...
... A targeted delivery combination selectively crosses the tight barrier that ... and bind to brain tumors, a research team led by ... reported in the January issue of the Journal of ... demonstrated that the targeted particles guide payloads to image tumors, ...
Cached Medicine News:Health News:Teens with HIV at high risk for pregnancy, complications 2Health News:More doctors must join nurses, administrators in leading efforts to improve patient safety, outcomes 2Health News:UofL Area Health Education Centers' faculty, students make $6.8 million economic impact 2Health News:UofL Area Health Education Centers' faculty, students make $6.8 million economic impact 3Health News:Targeted particle fools brain's guardian to reach tumors 2Health News:Targeted particle fools brain's guardian to reach tumors 3Health News:Targeted particle fools brain's guardian to reach tumors 4
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: